Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257491
Status:
COMPLETED
Last Update Posted:
2013-11-11
First Post:
2005-11-22
Brief Title:
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mgHydrochlorothiazide 125 mg Micardis Plus by Ambulatory Blood Pressure Monitoring ABPM in Patients With Mild to Moderate Essential Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
502488
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None